Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.42M 1.33M 1.21M 2.28M 157M 2.31M 15.58M 6.1M 78.58M 6.16M 6.03M 261M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.02M 6.58M 6M 11.28M 777M 11.43M 77.18M 30.24M 389M 30.52M 29.86M 1.3B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
3 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
+0.25%-0.22%+68.73%+116.60% 1,052B
+0.78%+1.21%+48.53%+52.20% 627B
+0.35%+1.74%+21.11%+65.18% 441B
+0.28%-3.05%+39.10%+36.65% 349B
+0.78%-2.05%+24.03%+36.97% 287B
+0.87%-2.82%-0.28%+6.27% 241B
+1.00%+2.05%+41.46%+58.24% 224B
-0.78%-4.16%-10.28%-53.87% 202B
+0.40%+4.29%+17.36%+78.10% 172B
Average +990.39%-1.09%+24.98%+39.63% 359.52B
Weighted average by Cap. +0.44%-1.70%+39.71%+62.49%

Financials

2007 2008
Net sales 23.47M 20.26M 19.01M 17.31M 32.55M 2.24B 33M 223M 87.31M 1.12B 88.1M 86.19M 3.74B 25.96M 22.41M 21.02M 19.15M 36.01M 2.48B 36.51M 246M 96.58M 1.24B 97.46M 95.35M 4.14B
Net income -20.86M -18.01M -16.89M -15.39M -28.93M -1.99B -29.33M -198M -77.6M -999M -78.31M -76.61M -3.32B -4.01M -3.46M -3.24M -2.96M -5.56M -383M -5.63M -38.03M -14.9M -192M -15.04M -14.71M -638M
Net Debt 18.79M 16.22M 15.22M 13.86M 26.06M 1.8B 26.42M 178M 69.91M 900M 70.55M 69.02M 2.99B 6.49M 5.6M 5.26M 4.79M 9M 620M 9.12M 61.6M 24.14M 311M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock